Health Care: Drugs

Dynavax Technologies Corp (DVAX: NASDAQ)

$9.9 n/a | n/a%
07/25/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 11.04M 4.05M 11.03M 11.25M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 11.04M 4.05M 11.03M 11.25M
Selling, General, and Administrative Expenses 37.26M 22.18M 17.38M 25.94M
Research & Development 84.49M 86.94M 84.58M 50.87M
Operating Income before D & A (EBITDA) -110.71M -105.07M -90.92M -65.56M
Depreciation & Amortization 2.44M 1.91M 2.29M 2.25M
Interest Income 755.00K 205.00K 191.00K 116.00K
Other Income - Net -2.49M -1.35M 433.00K -348.00K
Special Income / Charges 0.00 0.00 -386.00K -926.00K
Total Income Before Interest Expenses (EBIT) -114.88M -108.13M -92.97M -68.97M
Interest Expense 0.00 572.00K 35.00K 0.00
Pre-Tax Income -114.88M -108.70M -93.01M -68.97M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -112.44M -106.79M -90.72M -66.72M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -112.44M -106.79M -90.72M -66.72M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -112.44M -106.79M -90.72M -66.72M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-112.44M -106.79M -90.34M -65.79M
Preferred Dividends
Net Income Available To Common -112.44M -106.79M -90.72M -75.19M
Basic EPS from Continuing Ops. -2.92 -3.25 -3.45 -3.83
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.92 -3.25 -3.45 -3.83
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.92 -3.25 -3.45 -3.83
Basic Normalized Net Income/Share -2.92 -3.25 -3.44 -3.78
EPS fr Continuing Ops. -2.92 -3.25 -3.45 -3.83
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.92 -3.25 -3.45 -3.83
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.92 -3.25 -3.45 -3.83
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.92 -3.25 -3.44 -3.78
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DVAX

Latest DVAX Headlines from TheStreet

More Financial News for DVAX

Press Releases for DVAX

See All Press Releases

Partner Headlines for DVAX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter